153 related articles for article (PubMed ID: 36873211)
1. Measuring resilience by cognitive diagnosis models and its prediction of 6-month quality of life in Be Resilient to Breast Cancer (BRBC).
Liang MZ; Chen P; Knobf MT; Molassiotis A; Tang Y; Hu GY; Sun Z; Yu YL; Ye ZJ
Front Psychiatry; 2023; 14():1102258. PubMed ID: 36873211
[TBL] [Abstract][Full Text] [Related]
2. Resilience index improves prediction of 1-year decreased quality of life in breast cancer.
Liang MZ; Tang Y; Knobf MT; Molassiotis A; Chen P; Hu GY; Sun Z; Yu YL; Ye ZJ
J Cancer Surviv; 2023 Jun; 17(3):759-768. PubMed ID: 35932356
[TBL] [Abstract][Full Text] [Related]
3. Brain connectomics improve prediction of 1-year decreased quality of life in breast cancer: A multi-voxel pattern analysis.
Liang MZ; Tang Y; Chen P; Tang XN; Knobf MT; Hu GY; Sun Z; Liu ML; Yu YL; Ye ZJ
Eur J Oncol Nurs; 2024 Feb; 68():102499. PubMed ID: 38199087
[TBL] [Abstract][Full Text] [Related]
4. Measurement invariance of the 10-item resilience scale specific to cancer in Americans and Chinese: A propensity score-based multidimensional item response theory analysis.
Liang M; Chen P; Molassiotis A; Jeon S; Tang Y; Hu G; Zhu Y; Sun Z; Yu Y; Knobf TM; Ye Z
Asia Pac J Oncol Nurs; 2023 Feb; 10(2):100171. PubMed ID: 36632445
[TBL] [Abstract][Full Text] [Related]
5. State or trait? Measuring resilience by generalisability theory in breast cancer.
Ye ZJ; Zhang Z; Zhang XY; Tang Y; Chen P; Liang MZ; Sun Z; Yu YL
Eur J Oncol Nurs; 2020 Feb; 46():101727. PubMed ID: 32339909
[TBL] [Abstract][Full Text] [Related]
6. Effect of a mentor-based, supportive-expressive program, Be Resilient to Breast Cancer, on survival in metastatic breast cancer: a randomised, controlled intervention trial.
Ye ZJ; Qiu HZ; Liang MZ; Liu ML; Li PF; Chen P; Sun Z; Yu YL; Wang SN; Zhang Z; Liao KL; Peng CF; Huang H; Hu GY; Zhu YF; Zeng Z; Hu Q; Zhao JJ
Br J Cancer; 2017 Nov; 117(10):1486-1494. PubMed ID: 28926525
[TBL] [Abstract][Full Text] [Related]
7. Resilience patterns and transitions in the Be Resilient To Breast Cancer trial: an exploratory latent profile transition analysis.
Ye ZJ; Zhang Z; Tang Y; Liang J; Sun Z; Hu GY; Liang MZ; Yu YL
Psychooncology; 2021 Jun; 30(6):901-909. PubMed ID: 33689199
[TBL] [Abstract][Full Text] [Related]
8. Effect of a multidiscipline mentor-based program, Be Resilient to Breast Cancer (BRBC), on female breast cancer survivors in mainland China-A randomized, controlled, theoretically-derived intervention trial.
Ye ZJ; Liang MZ; Qiu HZ; Liu ML; Hu GY; Zhu YF; Zeng Z; Zhao JJ; Quan XM
Breast Cancer Res Treat; 2016 Aug; 158(3):509-22. PubMed ID: 27400910
[TBL] [Abstract][Full Text] [Related]
9. New resilience instrument for family caregivers in cancer: a multidimensional item response theory analysis.
Liang MZ; Tang Y; Chen P; Liang J; Sun Z; Hu GY; Yu YL; Ye ZJ
Health Qual Life Outcomes; 2021 Nov; 19(1):258. PubMed ID: 34794439
[TBL] [Abstract][Full Text] [Related]
10. Resilience and Quality of Life in Breast Cancer Patients.
Ristevska-Dimitrovska G; Filov I; Rajchanovska D; Stefanovski P; Dejanova B
Open Access Maced J Med Sci; 2015 Dec; 3(4):727-31. PubMed ID: 27275317
[TBL] [Abstract][Full Text] [Related]
11. Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.
Jakob A; Zahn MO; Nusch A; Werner T; Schnell R; Frank M; Hamm N; Däßler KU; Losem C; Welslau M; Hoevel P; Potthoff K
J Bone Oncol; 2022 Apr; 33():100420. PubMed ID: 35340302
[TBL] [Abstract][Full Text] [Related]
12. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
Hilden J; Gerds TA
Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
[TBL] [Abstract][Full Text] [Related]
13. Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction.
Wang C; Xu Y; Lin Y; Zhou Y; Mao F; Zhang X; Shen S; Zhang Y; Sun Q
Breast; 2022 Jun; 63():61-70. PubMed ID: 35334240
[TBL] [Abstract][Full Text] [Related]
14. The Role of Maternal Weight in the Hierarchy of Macrosomia Predictors; Overall Effect of Analysis of Three Prediction Indicators.
Lewandowska M
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33671089
[TBL] [Abstract][Full Text] [Related]
15. A classification model for continuous responses: Identifying risk perception groups on health-related activities.
de Oliveira ESB; Wang X; Bazán JL
Biom J; 2023 Apr; 65(4):e2100222. PubMed ID: 36782079
[TBL] [Abstract][Full Text] [Related]
16. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
Widera C; Pencina MJ; Meisner A; Kempf T; Bethmann K; Marquardt I; Katus HA; Giannitsis E; Wollert KC
Eur Heart J; 2012 May; 33(9):1095-104. PubMed ID: 22199121
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the effect of multiple genetic risk score models on colorectal cancer risk prediction.
Xin J; Chu H; Ben S; Ge Y; Shao W; Zhao Y; Wei Y; Ma G; Li S; Gu D; Zhang Z; Du M; Wang M
Gene; 2018 Oct; 673():174-180. PubMed ID: 29908285
[TBL] [Abstract][Full Text] [Related]
18. Efficient Models for Cognitive Diagnosis With Continuous and Mixed-Type Latent Variables.
Hong H; Wang C; Lim YS; Douglas J
Appl Psychol Meas; 2015 Jan; 39(1):31-43. PubMed ID: 29880992
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
